Related Experiment Video
Updated: Feb 5, 2026

VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance
Published on: August 23, 2013
A t(3;8)(q26.2;q24) involving the EVI1 (MECOM) Gene
Kristie Liu1,2, Carlos A Tirado1,3,4,5
1The International Circle of Genetic Studies, Los Angeles, CA.
Objectives:
Polycythemia vera (PV) is a Philadelphia chromosome-negative myeloproliferative neoplasm (MPN) primarily characterized by increased red blood cell production. We report a case of a 68-year-old male with a history of PV. About four years later, the patient developed myelofibrosis. A bone marrow biopsy confirmed the presence of myelofibrosis confirmed by a hypercellular bone marrow (80%) with increased reticulin fibrosis (MF2-3), 5% blasts, and a normal 46,XY karyotype. A follow-up bone marrow biopsy documented acute myeloid leukemia (post-polycythemic myelofibrosis with acute leukemic transformation) with 20-30% blasts in the bone marrow. Chromosome analysis revealed an abnormal male karyotype with a t(3;8)(q26.2;q23) involving MECOM (EVI1) on 11q23 and confirmed by FISH and no PVTI rearrangement. To the best of our knowledge, this translocation has not been reported in acute myeloid leukemia (AML), de novo or therapy related-myelodysplastic syndrome (MDS), or MDS or myeloproliferative disorder progressing to AML. However, further studies need to be conducted to elucidate and identify the roles of genes other than MECOM involved in this peculiar translocation with such a poor prognosis.
Insights
This case study details a patient with polycythemia vera who progressed to acute myeloid leukemia with a novel t(3;8) translocation. This rare genetic finding highlights a poor prognosis in myeloproliferative neoplasms.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) marked by excessive red blood cell production.
- PV can transform into myelofibrosis and subsequently acute myeloid leukemia (AML).
Purpose of the Study:
- To report a rare case of a patient with PV who developed myelofibrosis and then AML.
- To characterize a novel chromosomal translocation, t(3;8)(q26.2;q23), involving MECOM in AML secondary to PV.
Main Methods:
- Case report of a 68-year-old male with a history of PV.
- Bone marrow biopsies analyzed for cellularity, fibrosis, blast percentage, and karyotype.
- Fluorescence in situ hybridization (FISH) used to confirm the translocation.
Main Results:
- The patient progressed from PV to myelofibrosis and then to AML.
- A novel t(3;8)(q26.2;q23) translocation involving MECOM was identified in the AML phase.
- This specific translocation has not been previously reported in AML or related disorders.
Conclusions:
- The identified t(3;8) translocation represents a unique genetic event in post-PV AML.
- This translocation may be associated with a poor prognosis.
- Further research is needed to understand the role of MECOM and other genes in this translocation and its clinical impact.
More Related Videos
05:22Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring
Published on: January 20, 2023
09:54The Use of Induced Somatic Sector Analysis ISSA for Studying Genes and Promoters Involved in Wood Formation and Secondary Stem Development
Published on: October 5, 2016
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Gene Flow
Gene Conversion
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Therapy